dc.contributor.author | Neher, Jon O. | eng |
dc.contributor.author | Morton, Jacquelyn R. | eng |
dc.date.issued | 2004 | eng |
dc.description.abstract | Erythromycin, clarithromycin, and azithromycin are equally effective in treating pneumonia caused by Mycoplasma pneumoniae or Chlamydophila (formerly Chlamydia) pneumoniae (strength of recommendation [SOR]: B, small head-to-head trials). Macrolide choice can be based on other considerations--cost, side effects, and effectiveness against other suspected pathogens (SOR: C, expert opinion). | eng |
dc.identifier.uri | http://hdl.handle.net/10355/3205 | eng |
dc.language | English | eng |
dc.publisher | Family Physicians Inquiries Network | eng |
dc.relation.ispartofcollection | Clinical Inquiries, 2004 (MU) | eng |
dc.relation.ispartofcommunity | University of Missouri--Columbia. School of Medicine. Department of Family and Community Medicine. Family Physicians Inquiries Network | eng |
dc.relation.ispartofseries | Journal of family practice, 53, no. 03 (March 2004): 229-230. | eng |
dc.rights | OpenAccess. | eng |
dc.rights.license | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License. | eng |
dc.subject | side effects | eng |
dc.subject.lcsh | Mycoplasma Pneumoniae | eng |
dc.subject.lcsh | Chlamydophila Pneumoniae | eng |
dc.subject.lcsh | Macrolide Antibiotics | eng |
dc.subject.lcsh | Erythromycin | eng |
dc.title | What is the best macrolide for atypical pneumonia? | eng |
dc.type | Article | eng |